IPrEx
IPrEx
IPrEx (pronounced eye-prex) is an acronym for the Pre-exposure Prophylaxis Initiative, a clinical trial that studied the use of antiretroviral drugs as a means of preventing HIV infection in men who have sex with men and transgender women who have sex with men. The term "IPrEx" is derived from the words "pre-exposure prophylaxis" and "initiative".
Pronunciation
- IPA: /aɪprɛks/
Etymology
The term "IPrEx" is an acronym that stands for "Pre-exposure Prophylaxis Initiative". The term "prophylaxis" comes from the Greek word "prophylaktikos", meaning "guarding or preventing beforehand".
Related Terms
- Pre-exposure prophylaxis (PrEP): A strategy that involves the use of antiretroviral drugs to prevent HIV infection.
- Antiretroviral drugs: Medications used to manage HIV.
- HIV: Human Immunodeficiency Virus, the virus that causes AIDS.
- AIDS: Acquired Immunodeficiency Syndrome, a condition caused by HIV.
- Clinical trial: A type of research study that tests how well new medical approaches work in people.
See Also
References
External links
- Medical encyclopedia article on IPrEx
- Wikipedia's article - IPrEx
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski